Molecular Diagnostics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL MOLECULAR DIAGNOSTICS INDUSTRY

2.1 Summary about Molecular Diagnostics Industry

2.2 Molecular Diagnostics Market Trends

2.2.1 Molecular Diagnostics Production & Consumption Trends

2.2.2 Molecular Diagnostics Demand Structure Trends

2.3 Molecular Diagnostics Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Infectious Disease

4.2.2 Oncology

4.2.3 Genetics

4.2.4 Microbiology

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital

4.3.2 Laboratories

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Infectious Disease

5.2.2 Oncology

5.2.3 Genetics

5.2.4 Microbiology

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital

5.3.2 Laboratories

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Infectious Disease

6.2.2 Oncology

6.2.3 Genetics

6.2.4 Microbiology

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital

6.3.2 Laboratories

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Infectious Disease

7.2.2 Oncology

7.2.3 Genetics

7.2.4 Microbiology

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital

7.3.2 Laboratories

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Infectious Disease

8.2.2 Oncology

8.2.3 Genetics

8.2.4 Microbiology

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital

8.3.2 Laboratories

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Infectious Disease

9.2.2 Oncology

9.2.3 Genetics

9.2.4 Microbiology

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital

9.3.2 Laboratories

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Roche Diagnostics

10.1.2 QIAGEN N.V.

10.1.3 Hologic Inc

10.1.4 Grifols

10.1.5 Abbott Laboratories

10.1.6 Siemens Healthcare

10.1.7 Becton, Dickinson

10.1.8 Beckman Coulter

10.1.9 bioM?rieux SA

10.1.10 Cepheid

10.2 Molecular Diagnostics Sales Date of Major Players (2017-2020e)

10.2.1 Roche Diagnostics

10.2.2 QIAGEN N.V.

10.2.3 Hologic Inc

10.2.4 Grifols

10.2.5 Abbott Laboratories

10.2.6 Siemens Healthcare

10.2.7 Becton, Dickinson

10.2.8 Beckman Coulter

10.2.9 bioM?rieux SA

10.2.10 Cepheid

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Molecular Diagnostics Product Type Overview

2.Table Molecular Diagnostics Product Type Market Share List

3.Table Molecular Diagnostics Product Type of Major Players

4.Table Brief Introduction of Roche Diagnostics

5.Table Brief Introduction of QIAGEN N.V.

6.Table Brief Introduction of Hologic Inc

7.Table Brief Introduction of Grifols

8.Table Brief Introduction of Abbott Laboratories

9.Table Brief Introduction of Siemens Healthcare

10.Table Brief Introduction of Becton, Dickinson

11.Table Brief Introduction of Beckman Coulter

12.Table Brief Introduction of bioM?rieux SA

13.Table Brief Introduction of Cepheid

14.Table Products & Services of Roche Diagnostics

15.Table Products & Services of QIAGEN N.V.

16.Table Products & Services of Hologic Inc

17.Table Products & Services of Grifols

18.Table Products & Services of Abbott Laboratories

19.Table Products & Services of Siemens Healthcare

20.Table Products & Services of Becton, Dickinson

21.Table Products & Services of Beckman Coulter

22.Table Products & Services of bioM?rieux SA

23.Table Products & Services of Cepheid

24.Table Market Distribution of Major Players

25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

27.Table Global Molecular Diagnostics Market Forecast (Million USD) by Region 2021f-2026f

28.Table Global Molecular Diagnostics Market Forecast (Million USD) Share by Region 2021f-2026f

29.Table Global Molecular Diagnostics Market Forecast (Million USD) by Demand 2021f-2026f

30.Table Global Molecular Diagnostics Market Forecast (Million USD) Share by Demand 2021f-2026f